These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 141914)

  • 21. The regulation of hypoxanthine guanine phosphoribosyl transferase activity through transfer of PRPP by metabolic cooperation.
    Vitkauskas G; Canellakis ES
    Exp Cell Res; 1984 Jun; 152(2):541-51. PubMed ID: 6202536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Schapiro MB; Haxby JV; Grady CL; Duara R; Schlageter NL; White B; Moore A; Sundaram M; Larson SM; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):766-74. PubMed ID: 2956363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologically induced erythrocyte PP-ribose-P variations.
    Pompucci G; Micheli V; Marcolongo R
    Adv Exp Med Biol; 1977; 76A():529-34. PubMed ID: 855727
    [No Abstract]   [Full Text] [Related]  

  • 24. An improved method for the determination of 5-phosphoribosyl 1-pyrophosphate.
    Micheli V; Pompucci G; Marcolongo R
    Clin Chim Acta; 1975 Dec; 65(2):181-5. PubMed ID: 1183052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythrocyte ATP: D-fructose-6-phosphate 1-phosphotransferase (phosphofructokinase) activity in children with normałG trisomic mosaic Down's syndrome and in normal and Down's syndrome controls.
    Benson PF; Linacre B; Taylor AI
    Nature; 1968 Dec; 220(5173):1235-6. PubMed ID: 4302265
    [No Abstract]   [Full Text] [Related]  

  • 26. Phosphoribosylpyrophosphate synthesis in human erythrocytes: inhibition by purine nucleosides.
    Planet G; Fox IH
    Adv Exp Med Biol; 1977; 76A():64-70. PubMed ID: 855736
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence for early mitogenic stimulation of metabolic flux through phosphoribosyl pyrophosphate into nucleotides in Swiss 3T3 cells.
    Ishijima S; Kita K; Kinoshita N; Ishizuka T; Suzuki N; Tatibana M
    J Biochem; 1988 Oct; 104(4):570-5. PubMed ID: 2467906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of phosphoribosylpyrophosphate synthesis by purine nucleosides in human erythrocytes.
    Planet G; Fox IH
    J Biol Chem; 1976 Oct; 251(19):5839-44. PubMed ID: 972142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in pathways of pentose phosphate formation in relation to phosphoribosyl pyrophosphate synthesis in the developing rat kidney. Effects of glucose concentration and electron acceptors.
    Sochor M; Kunjara S; Greenbaum AL; McLean P
    J Dev Physiol; 1989 Sep; 12(3):135-43. PubMed ID: 2483165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stimulation of purine nucleotide production by pyrroline-5-carboxylic acid in human erythrocytes.
    Yeh GC; Phang JM
    Biochem Biophys Res Commun; 1981 Nov; 103(1):118-24. PubMed ID: 6172124
    [No Abstract]   [Full Text] [Related]  

  • 32. Red blood cell glucose metabolism in Down's syndrome.
    Magnani M; Stocchi V; Novelli G; Dachà M; Fornaini G
    Clin Physiol Biochem; 1987; 5(1):9-14. PubMed ID: 2953518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated erythrocyte adenosine deaminase activity in Down's syndrome.
    Puukka R; Puukka M; Linna SL; Joensuu T; Kouvalainen K
    Acta Paediatr Scand; 1981 Sep; 70(5):739-41. PubMed ID: 6459708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leucocyte alkaline phosphatase and erythrocyte glucose-6-phosphate dehydrogenase in Down's Syndrome.
    Phillips J; Herring RM; Goodman HO; King JS
    J Med Genet; 1967 Dec; 4(4):268-73. PubMed ID: 4230173
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial distribution of increased erythrocyte PP-ribose-P levels.
    Marcolongo R; Pompucci G; Micheli V
    Adv Exp Med Biol; 1977; 76A():280-6. PubMed ID: 193371
    [No Abstract]   [Full Text] [Related]  

  • 36. Phosphoribosylpyrophosphate in erythrocytes of ten mammalian species: concentration, synthesis and degradation.
    Tax WJ; Veerkamp JH
    Comp Biochem Physiol B; 1978; 59(3):219-22. PubMed ID: 95678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pool and synthesis of phosphoribosylpyrophosphate in rat embryo cells infected with X14 or H-1 parvovirus.
    Avola R; Ragusa N; Castro A; Ricceri G
    Boll Soc Ital Biol Sper; 1981 Nov; 57(22):2235-40. PubMed ID: 6173048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythrocyte glucose-6 phosphate dehydrogenase (G6PD) and Australia antigen hepatitis in Down's syndrome.
    Sutnick AI; Oski FA; London WT; Millman I; Blumberg BS
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):3-8. PubMed ID: 4257700
    [No Abstract]   [Full Text] [Related]  

  • 39. Differences in purine metabolism in patients with Down's syndrome.
    Peeters MA; Megarbane A; Cattaneo F; Rethore MO; Lejeune J
    J Intellect Disabil Res; 1993 Dec; 37 ( Pt 6)():491-505. PubMed ID: 8123996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The formation of 5-phosphoribosyl-1-pyrophosphate in human leukemic leukocytes.
    Higuchi T; Nakamura T; Wakisaka G
    Biochem Med; 1975 Jun; 13(2):178-83. PubMed ID: 1191275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.